RSS   Newsletter   Contact   Advertise with us
Post Online Media

Taro appoints interim CEO

Taro PharmaceuticalTaro Pharmaceutical Industries, a research-based pharmaceutical manufacturer, appointed Abhay Gandhi to the position of interim chief executive officer from January 1, 2017.
Article continues below

READ MORE Amarin appoints Michael W. Kalb as CFO

Mr. Gandhi currently serves as the CEO of the Sun Pharmaceutical Industries North America operations. Taro’'s Board of Directors has also nominated Mr. Gandhi to its Board.

Prior to joining Sun Pharma’s North America business, Mr. Gandhi held several leadership positions within Sun Pharma over the last 20 years, including most recently, as CEO of its India business.

He was responsible for India operations as well as certain international markets, including sales & marketing, integration efforts, business development, portfolio management and other allied functions.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy